Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells

被引:106
作者
Celia, Christian [1 ,2 ]
Trapasso, Elena [3 ]
Locatelli, Marcello [1 ]
Navarra, Michele [4 ]
Ventura, Cinzia Anna [4 ]
Wolfram, Joy [2 ,5 ]
Carafa, Maria [6 ]
Morittu, Valeria Maria [3 ]
Britti, Domenico [3 ]
Di Marzio, Luisa [1 ]
Paolino, Donatella [3 ]
机构
[1] Univ G dAnnunzio, Dept Pharm, I-66013 Chieti, Italy
[2] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy
[4] Univ Messina, Dept Drug Sci & Hlth Prod, I-98168 Messina, Italy
[5] Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
[6] Univ Roma La Sapienza, Dept Drug Chem & Technol, I-00185 Rome, Italy
关键词
Natural products; Liposomes; Bergamot essential oil (BEO); Citrus extracts; Cancer; SH-SY5Y human neuroblastoma cells; OF-THE-ART; IN-VITRO; ANTIINFLAMMATORY ACTIVITY; PHARMACOKINETIC FEATURES; INHIBITS PROLIFERATION; POTENTIAL TREATMENT; CITRUS LIMONOIDS; GEMCITABINE; DELIVERY; APOPTOSIS;
D O I
10.1016/j.colsurfb.2013.09.017
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Citrus extracts, particularly bergamot essential oil (BEO) and its fractions, have been found to exhibit anticancer efficacy. However, the poor water solubility, low stability and limited bioavailability have prevented the use of BEO in cancer therapy. To overcome such drawbacks, we formulated BEO liposomes that improved the water solubility of the phytocomponents and increased their anticancer activity in vitro against human SH-SY5Y neuroblastoma cells. The results warrant further investigation of BEO liposomes for in vivo applications. (C) 2013 Published by Elsevier B.V.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 42 条
[1]  
Bardon S, 1998, NUTR CANCER, V32, P1, DOI 10.1080/01635589809514708
[2]   Toxic profile of bergamot essential oil on survival and proliferation of SH-SY5Y neuroblastoma cells [J].
Berliocchi, Laura ;
Ciociaro, Antonella ;
Russo, Rossella ;
Cassiano, Maria Gilda Valentina ;
Blandini, Fabio ;
Rotiroti, Domenicantonio ;
Morrone, Luigi Antonio ;
Corasaniti, Maria Tiziana .
FOOD AND CHEMICAL TOXICOLOGY, 2011, 49 (11) :2780-2792
[3]  
Butler Mark S., 2008, V65
[4]  
Calvagno Maria Grazia, 2007, Current Drug Delivery, V4, P89
[5]   Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo [J].
Celano, M. ;
Schenone, S. ;
Cosco, D. ;
Navarra, M. ;
Puxeddu, E. ;
Racanicchi, L. ;
Brullo, C. ;
Varano, E. ;
Alcaro, S. ;
Ferretti, E. ;
Botta, G. ;
Filetti, S. ;
Fresta, M. ;
Botta, M. ;
Russo, D. .
ENDOCRINE-RELATED CANCER, 2008, 15 (02) :499-510
[6]   Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders [J].
Celia, Christian ;
Cilurzo, Felisa ;
Trapasso, Elena ;
Cosco, Donato ;
Fresta, Massimo ;
Paolino, Donatella .
BIOMEDICAL MICRODEVICES, 2012, 14 (01) :119-130
[7]   Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features and in vivo antitumor activity [J].
Celia, Christian ;
Cosco, Donato ;
Paolino, Donatella ;
Fresta, Massimo .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (12) :1609-1629
[8]   Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells [J].
Celia, Christian ;
Malara, Natalia ;
Terracciano, Rosa ;
Cosco, Donato ;
Paolino, Donatella ;
Fresta, Massimo ;
Savino, Rocco .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2008, 4 (02) :155-166
[9]  
Cenci E, 2012, NAT PROD COMMUN, V7, P143
[10]   Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes [J].
Coimbra, Maria ;
Isacchi, Benedetta ;
van Bloois, Louis ;
Torano, Javier Sastre ;
Ket, Aldo ;
Wu, Xiaojie ;
Broere, Femke ;
Metselaar, Josbert M. ;
Rijcken, Cristianne J. F. ;
Storm, Gert ;
Bilia, Rita ;
Schiffelers, Raymond M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 416 (02) :433-442